Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Gaziantep
Clinical trial register · Turkey

Clinical Trials in Gaziantep, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Turkey and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5418 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5418
Studies in scope
all four open statuses
2461
Recruiting now
open to new participants
548
Lead sponsors
across recruiting studies
Top sites
Istanbul 21 Ankara 21 Adana 13 Izmir 13 Gaziantep 8
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Hasan Kalyoncu University20 University of Gaziantep11 Pfizer8 Sanko University6 Eli Lilly and Company6 Clear sponsor filter
Site location
Istanbul21 Ankara21 Adana13 Izmir13 Gaziantep8
All 26 locations
Target enrolment
to

Trials with a site in Gaziantep

8 of 5418 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Turkey
Start
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsPF-08634404·Pembrolizumab
Pfizer
Phase 3
1,410
Istanbul, Üsküdar / İstanbul, Adana, Ankara, Diyarbakır, Gaziantep, Samsun
2026-01-06
Recruiting
Pfizer
Phase 3
300
Istanbul, Ankara, Gaziantep, Kocaeli, Sakarya, Trabzon
2025-07-14
Recruiting
Pfizer
Phase 3
2,330
Istanbul, Ankara, Gaziantep, Kocaeli, Sakarya, Trabzon
2024-12-08
Recruiting
Pfizer
Phase 3
173
Izmir, Adana, Gaziantep, Istanbul
2022-12-28
Recruiting
Pfizer
Phase 3
245
Adana, Ankara, Gaziantep, Istanbul, Izmir, Kayseri, Samsun
2021-11-17
Recruiting
Pfizer
Phase 3
893
Istanbul, Izmir, Adana, Ankara, Antalya, Gaziantep, Kayseri, Kocaeli
2021-10-04
Active, closed
Pfizer
Phase 3
77
Adana, Gaziantep, Izmir
2020-08-18
Active, closed
Pfizer
Phase 3
51
Adana, Gaziantep, Istanbul, Izmir
2019-07-29
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Turkish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-turkey/city/gaziantep

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Turkey and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,418 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Gaziantep that also match the filters currently applied.

How many clinical trials are recruiting in Gaziantep?

6 of the 8 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 2 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Gaziantep), 8 studies
PhaseStudiesRecruitingShare
Phase 386100%

Most active sponsors

Lead sponsors with the most studies (Gaziantep)
Lead sponsorStudiesRecruiting
Pfizer86
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.